ABCA1-Mediated EMT Promotes Papillary Thyroid Cancer Malignancy through the ERK/Fra-1/ZEB1 Pathway
Cells · 10.01.2023 · 12 (2) · 274
DOI: 10.3390/cells12020274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 10.01.2023. Verfasst von Ji-Hye Park und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Radiation Exposure & Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological & Medical Science, Seou…. Hauptthemen laut MEDLINE: Lung Neoplasms, Thyroid Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Radiological and Medical Sciences (KIRAMS), Hanyang University, Republic of Korea.
Abstract (Originalsprache)
Papillary thyroid cancer (PTC) is the most prevalent histological type of thyroid cancer (TC) worldwide. Although tumor metastasis occurs in regional lymph nodes, distant metastasis (DM) may also occur. Radioactive iodine (RAI) therapy is an effective treatment for TC; however, resistance to RAI occurs in patients with DM. Therefore, in this study, we investigated the efficacy of DM-related biomarkers as therapeutic targets for PTC therapy. ABCA1 expression was higher in aggressive BCPAP cells than in other PTC cells in terms of migration and invasion capacity. The knockdown of ABCA1 substantially decreased the expression of the epithelial–mesenchymal transition (EMT) marker, N-cadherin, and EMT regulator (ZEB1), resulting in suppressed migration and invasion of BCPAP cells. ABCA1 knockdown also reduced ERK activity and Fra-1 expression, which correlated with the effects of an ERK inhibitor or siRNA-mediated inhibition of ERK or Fra-1 expression. Furthermore, ABCA1-knocked-down BCPAP cells suppressed cell migration and invasion by reducing Fra-1 recruitment to Zeb1 promoter; lung metastasis was not observed in mice injected with ABCA1-knocked-down cells. Overall, our findings suggest that ABCA1 regulates lung metastasis in TC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Radiation Exposure & Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological & Medical Science, Seoul 01812, Republic of Korea.
- OPTOLANE Technologies Inc., Seongnam 13494, Republic of Korea.
- Department of Pathology, College of Medicine, Hanyang University, Seoul 01812, Republic of Korea.
- Laboratory of Experimental Pathology, Departments of Pathology, Korea Institute of Radiological & Medical Science, Seoul 01812, Republic of Korea.
- Biohealth Convergence, Seoul Women's University, Seoul 01812, Republic of Korea.
ORCID-Profile: Ji-Hye Park, Jae-Kyung Myung, Seung-Bum Lee
Förderung
- Korea Institute of Radiological and Medical Sciences (KIRAMS)
- Hanyang University, Republic of Korea
Zitieren
APA
Park, J. H., Myung, J. K., Lee, S. J., Kim, H., Kim, S., Lee, S. B., Jang, H., Jang, W. I., Park, S., Yang, H., Shim, S., & Kim, M. J. (2023). ABCA1-Mediated EMT Promotes Papillary Thyroid Cancer Malignancy through the ERK/Fra-1/ZEB1 Pathway. Cells, 12(2), 274. https://doi.org/10.3390/cells12020274
Vancouver
Park JH, Myung JK, Lee SJ, Kim H, Kim S, Lee SB, et al. ABCA1-Mediated EMT Promotes Papillary Thyroid Cancer Malignancy through the ERK/Fra-1/ZEB1 Pathway. Cells. 2023;12(2):274. doi:10.3390/cells12020274
BibTeX
@article{Park2023,
author = {Park, Ji-Hye and Myung, Jae-Kyung and Lee, Sun-Joo and Kim, Hyewon and Kim, Soyeon and Lee, Seung-Bum and Jang, Hyosun and Jang, Won-Il and Park, Sunhoo and Yang, Hyunwon and Shim, Sehwan and Kim, Min-Jung},
title = {ABCA1-Mediated EMT Promotes Papillary Thyroid Cancer Malignancy through the ERK/Fra-1/ZEB1 Pathway},
journal = {Cells},
year = {2023},
volume = {12},
number = {2},
pages = {274},
doi = {10.3390/cells12020274}
}
EUVIMED